FTC Updating Product Endorsement Rules; Asks Rx Industry To Comment
Executive Summary
The Federal Trade Commission wants comments from the pharmaceutical industry about its guidelines governing paid product endorsements, Division of Advertising Practices Assistant Director Thomas Pahl told a Food & Drug Law Institute conference Sept. 12 in Washington, D.C
You may also be interested in...
DTC Guidances Could Limit Use Of Celebrity Endorsers Outside Of Product Ads
Manufacturers may need to reevaluate their use of celebrity endorsers in light of FDA's draft DTC guidances to ensure that disease awareness ads are distinct from product-specific ads
DTC Guidances Could Limit Use Of Celebrity Endorsers Outside Of Product Ads
Manufacturers may need to reevaluate their use of celebrity endorsers in light of FDA's draft DTC guidances to ensure that disease awareness ads are distinct from product-specific ads
Print Ads Should Use Limited “Brief Summary” Like TV Spots, FTC Tells FDA
The Federal Trade Commission is encouraging FDA to ease its requirements for direct-to-consumer print advertisements and allow them to include a more limited "brief summary" like TV ads do